The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Amphotericin B Formulations and Drug Targeting
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Amphotericin B: 30 Years of Clinical Experience
Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,009
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
(1999) · Journal of Equine Veterinary Science · doi:10.1016/s0737-0806(99)80080-x · Cited by 801
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Therapeutic Outcome in Invasive Aspergillosis
Denning, D. W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.608 · Cited by 689
Kirby, C., Clarke, J., & Gregoriadis, G. (1980) · Biochemical Journal · doi:10.1042/bj1860591 · Cited by 592
Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles
Papahadjopoulos, D., Vail, W. J., Jacobson, K., & Poste, G. (1975) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(75)90299-0 · Cited by 545
Wingard, J. R., White, M. H., Anaissie, E., Raffalli, J., Goodman, J., Arrieta, A., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 527
Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., Dasbach, E. J., & Platt, R. (2001) · Clinical Infectious Diseases · doi:10.1086/319211 · Cited by 451
Amphotericin B: time for a new “gold standard”
Saravolatz, L. D., Ostrosky-Zeichner, L., Marr, K. A., Rex, J. H., & Cohen, S. H. (2003) · Clinical Infectious Diseases · doi:10.1086/376634 · Cited by 406
Walsh, T. J., Goodman, J. L., Pappas, P., Bekersky, I., Buell, D. N., Roden, M., Barrett, J., & Anaissie, E. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3487-3496.2001 · Cited by 401
Wingard, J. R., Kubilis, P., Lee, L., Yee, G., White, M., Louise, W., Bowden, R., Anaissie, E., Hiemenz, J., & Lister, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313498 · Cited by 368
Bern, C., Adler‐Moore, J., Berenguer, J., Boelaert, M., Boer, M. D., Davidson, R. N., Figueras, C., Gradoni, L., Kafetzis, D. A., Ritmeijer, K., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507530 · Cited by 345
AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience
Adler-Moore, J., & Proffitt, R. T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.21 · Cited by 339
Bowden, R., Chandrasekar, P., White, M. H., Li, X., Pietrelli, L., Gurwith, M., van Burik, J., Laverdiere, M., Safrin, S., & Wingard, J. R. (2002) · Clinical Infectious Diseases · doi:10.1086/341401 · Cited by 335
Bekersky, I., Fielding, R. M., Dressler, D. E., Lee, J. W., Buell, D. N., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.828-833.2002 · Cited by 319
Carrier effects on biological activity of amphotericin B
Brajtburg, J., & Bolard, J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.512 · Cited by 310
Lemke, A., Kiderlen, A. F., & Kayser, O. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1955-9 · Cited by 305
Leenders, A. C. A. P., Reiss, P., Portegies, P., Clezy, K., Hop, W. C. J., Hoy, J., Borleffs, J. C. C., Allworth, T., Kauffmann, R. H., Jones, P., et al. (1997) · AIDS · doi:10.1097/00002030-199712000-00010 · Cited by 289
Liposomal and Lipid Formulations of Amphotericin B: Clinical Pharmacokinetics
Janknegt, R., de Marie, S., Bakker-Woudenberg, I. A. J. M., & Crommelin, D. J. A. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223040-00004 · Cited by 274
Bolard, J., Legrand, P., Heitz, F., & Cybulska, B. (1991) · Biochemistry · doi:10.1021/bi00237a011 · Cited by 268
Amphotericin B Pharmacokinetics in Humans
Atkinson, A. J., & Bennett, J. E. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.2.271 · Cited by 267
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial
Meunier, F., Prentice, H. G., & Ringden, O. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.suppl_b.83 · Cited by 247
Bekersky, I., Fielding, R. M., Dressler, D. E., Lee, J. W., Buell, D. N., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.834-840.2002 · Cited by 236
Eriksson, U., Seifert, B., & Schaffner, A. (2001) · BMJ · doi:10.1136/bmj.322.7286.579 · Cited by 236
SCHWARZ, C. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289185 · Cited by 235
AmBisome (Liposomal Amphotericin B): A Comparative Review
Boswell, G. W., Buell, D., & Bekersky, I. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04464.x · Cited by 227
Unusual lipid structures selectively reduce the toxicity of amphotericin B.
Janoff, A. S., Boni, L. T., Popescu, M. C., Minchey, S. R., Cullis, P. R., Madden, T. D., Taraschi, T., Gruner, S. M., Shyamsunder, E., & Tate, M. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6122 · Cited by 223
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents
Proffitt, R. T., Satorius, A., Chiang, S.-M., Sullivan, L., & Adler-Moore, J. P. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.suppl_b.49 · Cited by 203
Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes
Legrand, P., Romero, E. A., Cohen, B. E., & Bolard, J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2518 · Cited by 201
Bazile, D. V., Ropert, C., Huve, P., Verrecchia, T., Mariard, M., Frydman, A., Veillard, M., & Spenlehauer, G. (1992) · Biomaterials · doi:10.1016/0142-9612(92)90142-b · Cited by 200
Sharkey, P. K., Graybill, J. R., Johnson, E. S., Hausrath, S. G., Pollard, R. B., Kolokathis, A., Mildvan, D., Fan-Havard, P., Eng, R. H. K., Patterson, T. F., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.315 · Cited by 197
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations
Barrett, J. P., Vardulaki, K. A., Conlon, C., Cooke, J., Daza-Ramirez, P., Evans, E. G. V., Hawkey, P. M., Herbrecht, R., Marks, D. I., Moraleda, J. M., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80125-x · Cited by 190
Walsh, T. J., Yeldandi, V., McEvoy, M., Gonzalez, C., Chanock, S., Freifeld, A., Seibel, N. I., Whitcomb, P. O., Jarosinski, P., Boswell, G., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2391 · Cited by 189
Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations
Sundar, S., Mehta, H., Suresh, A. V., Singh, S. P., Rai, M., & Murray, H. W. (2004) · Clinical Infectious Diseases · doi:10.1086/380971 · Cited by 189
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Clinical Pharmacokinetics of Systemic Antifungal Drugs
Daneshmend, T. K., & Warnock, D. W. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308010-00002 · Cited by 177
Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis
Girois, S. B., Chapuis, F., Decullier, E., & Revol, B. G. P. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0080-0 · Cited by 173
Yardley, V., & Croft, S. L. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00133-8 · Cited by 163
Potassium fluxes, first indications of membrane damage in micro-organisms
Lambert, P. A., & Hammond, S. M. (1973) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(73)91494-0 · Cited by 163
Amphotericin B lipid complex therapy of experimental fungal infections in mice
Clark, J. M., Whitney, R. R., Olsen, S. J., George, R. J., Swerdel, M. R., Kunselman, L., & Bonner, D. P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.4.615 · Cited by 159
Cagnoni, P. J., Walsh, T. J., Prendergast, M. M., BODENSTEINER, D. C., Hiemenz, S., Greenberg, R. N., Arndt, C. A. S., Schuster, M. G., Seibel, N. L., Yeldandi, V. V., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2476 · Cited by 153
Advances in the treatment of leishmaniasis
Sundar, S., & Rai, M. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200212000-00007 · Cited by 153
Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis
Santangelo, R., Paderu, P., Delmas, G., Chen, Z.-W., Mannino, R., Zarif, L., & Perlin, D. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2356-2360.2000 · Cited by 150
What is the current and future status of conventional amphotericin B?
Kleinberg, M. E. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.013 · Cited by 149
The Formation of Amphotericin B Ion Channels in Lipid Bilayers
Fujii, G., Chang, J.-E., Coley, T. R., & Steere, B. A. (1997) · Biochemistry · doi:10.1021/bi962894z · Cited by 148
Adams, M. L., & Kwon, G. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00347-4 · Cited by 143
Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B
Bolard, J., Seigneuret, M., & Boudet, G. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90074-7 · Cited by 136
Lee, J. W., Amantea, M., Francis, P. A., Navarro, E. E., Bacher, J. D., Pizzo, P. A., & Walsh, T. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.713 · Cited by 134
Clinical use of liposomal and lipid-complexed amphotericin B
de Marie, S., Janknegt, R., & Bakker‐Woudenberg, I. A. J. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.5.907 · Cited by 133
Effect of salt supplementation on amphotericin B nephrotoxicity
Llanos, A., Cieza, J. A., Bernardo, J., Echevarría, J., Biaggioni, I., Sabra, R., & Branch, R. A. (1991) · Kidney International · doi:10.1038/ki.1991.214 · Cited by 129
A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations
Shameem, M., Lee, H., & DeLuca, P. P. (1999) · AAPS PharmSci · doi:10.1208/ps010307 · Cited by 125
Johnson, E. M., Ojwang, J. O., Székely, A., Wallace, T. L., & Warnock, D. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1412 · Cited by 118
Moreau, P., Milpied, N. J., Fayette, N., Ramée, J., & Harousseau, J. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.4.535 · Cited by 118
Fielding, R. M., Smith, P. C., Wang, L. H., Porter, J., & Guo, L. S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1208 · Cited by 117
Andes, D., Safdar, N., Marchillo, K., & Conklin, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.674-684.2006 · Cited by 116
Fielding, R. M., Singer, A. W., Wang, L. H., Babbar, S., & Guo, L. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.299 · Cited by 110
Moreno, M. A., Ballesteros, M. P., & Frutos, P. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10412 · Cited by 105
Self-citationKirsh, R. L., Goldstein, R., Tarloff, J. B., Parris, D., Hook, J., Hanna, N., Bugelski, P. J., & Poste, G. H. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.5.1065 · Cited by 103
Adams, M. L., Andes, D. R., & Kwon, G. S. (2003) · Biomacromolecules · doi:10.1021/bm0257614 · Cited by 102
Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B
Anaissie, E. J., Paetznick, V. L., Proffitt, R. T., Adler‐Moore, J., & Bodey, G. P. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975823 · Cited by 102
Management of neonatal candidiasis
Rowen, J. L., & Tate, J. M. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199811000-00008 · Cited by 97
Block Copolymer Micelles for the Encapsulation and Delivery of Amphotericin B
Lavasanifar, A., Samuel, J., Sattari, S., & Kwon, G. S. (2002) · Pharmaceutical Research · doi:10.1023/a:1015127225021 · Cited by 96
Kan, V. L., Bennett, J. E., Amantea, M., Smolskis, M. C., McManus, E., Grasela, D. M., & Sherman, J. W. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.2.418 · Cited by 93
Adedoyin, A. B., Bernardo, J. F., Swenson, C. E., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2201 · Cited by 92
Intrathecal amphotericin in the management of coccidioidal meningitis1
Stevens, D. A. (2001) · Seminars in Respiratory Infections · doi:10.1053/srin.2001.29298 · Cited by 91
The lipid formulations of amphotericin B
Herbrecht, R., Natarajan‐Amé, S., Nivoix, Y., & Letscher‐Bru, V. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.8.1277 · Cited by 90
Hertenstein, B., Kern, W. V., Schmeiser, T., Štefanič, M., Bunjes, D. W., Wiesneth, M., Novotný, J., Heimpel, H., & Arnold, R. (1994) · Annals of Hematology · doi:10.1007/bf01695915 · Cited by 87
Milhaud, J., Ponsinet, V., Takashi, M., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00416-3 · Cited by 81
The effect of surfactants on the aggregation state of amphotericin B
Tancrède, P., Barwicz, J., Jutras, S., & Gruda, I. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90305-8 · Cited by 80
Sanders, S. W., Buchi, K. N., Goddard, M. S., Lang, J. K., & Tolman, K. G. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1029 · Cited by 80
Tissue Distribution of Amphotericin B Lipid Complex in Laboratory Animals
Olsen, S., Swerdel, M. R., Blue, B., Clark, J. M., & BONNER, D. P. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03189.x · Cited by 79
Caillot, D., Casasnovas, O., Solary, É., et al. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.1.161 · Cited by 78
Olson, J. A., Adler‐Moore, J., Schwartz, J., Jensen, G. M., & Proffitt, R. T. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00315-06 · Cited by 74
Study of Renal Safety in Amphotericin B Lipid Complex–Treated Patients
Alexander, B. D., & Wingard, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/429335 · Cited by 73
Erjavec, Z., Woolthuis, G., de Vries-Hospers, H. G., Sluiter, W. J., Daenen, S. M. G. J., de Pauw, B., & Halie, M. R. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01726364 · Cited by 72
Chandrasekar, P. H., & Ito, J. I. (2005) · Clinical Infectious Diseases · doi:10.1086/429333 · Cited by 71
Amphotericin B and its delivery by liposomal and lipid formulations
Gates, C., & Pinney, R. J. (1993) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1993.tb00605.x · Cited by 70
Espuelas, S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg351 · Cited by 70
Lipid-based formulations of amphotericin B
Veerareddy, P. R., & Vobalaboina, V. (2004) · Drugs of today · doi:10.1358/dot.2004.40.2.799425 · Cited by 68
Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis
Girois, S. B., Chapuis, F. R., Decullier, É., & Revol, B. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1281-2 · Cited by 67
Drug Delivery by Lipid Cochleates
Zarif, L. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91018-5 · Cited by 64
Moreno, M. A., Frutos, P., & Ballesteros, M. P. (2001) · Pharmaceutical Research · doi:10.1023/a:1011011215418 · Cited by 61
Self-citationCharvalos, E., Tzatzarakis, M. N., Françoise Van Bambeke, A., Tulkens, P. M., Tsatsakis, A. M., Tzanakakis, G. N., & Mingeot‐Leclercq, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki455 · Cited by 57
Ayestarán, A., López, R. M., Montoro, J. B., Estíbalez, A., Pou, L., Juliá, A., López, A., & Pascual, B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.609 · Cited by 55
Mehta, P. A., Vinks, A. A. T. M. M., Filipovich, A. H., Vaughn, G., Fearing, D., Sper, C., & Davies, S. M. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2005.10.010 · Cited by 54
Effect of the aggregation state of amphotericin B on its interaction with ergosterol
Gruda, I., & Dussault, N. (1988) · Biochemistry and Cell Biology · doi:10.1139/o88-024 · Cited by 51
Successful Use of Amphotericin B Lipid Complex in the Treatment of Cryptococcosis
Baddour, L. M., Perfect, J. R., & Ostrosky‐Zeichner, L. (2005) · Clinical Infectious Diseases · doi:10.1086/429337 · Cited by 51
Effect of tissue penetration on AmBisome efficacy.
Adler‐Moore, J., & Proffitt, R. T. (2003) · PubMed · Cited by 48
Drew, R. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.018 · Cited by 48
Adedoyin, A. B., Swenson, C. E., Bolcsak, L. E., Hellmann, A. R., Radowska, D., Horwith, G., Janoff, A. S., & Branch, R. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2900-2902.2000 · Cited by 46
Martino, R. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003179 · Cited by 44
Disposition of Aerosolized Liposomal Amphotericin B
Lambros, M. P., Bourne, D. W. A., Abbas, S. A., & Johnson, D. L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9604218 · Cited by 44
Mehta, J. (1997) · Leukemia Research · doi:10.1016/s0145-2126(96)00075-6 · Cited by 37
Bekersky, I., Fielding, R. M., Dressler, D. E., Kline, S., Buell, D. N., & Walsh, T. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/009127000104100906 · Cited by 35
Neonatal Fungemia and Amphotericin B
Glick, C., Graves, G. R., & Feldman, S. (1993) · Southern Medical Journal · doi:10.1097/00007611-199312000-00009 · Cited by 34
Amphotericin B lipid complex for the treatment of invasive fungal infections
Linden, P. K. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.2099 · Cited by 34
Menez, C., Buyse, M., Besnard, M., Farinotti, R., Loiseau, P. M., & BARRATT, G. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00837-06 · Cited by 34
Otsubo, T., Maesaki, S., Hossain, M. A., Yamamoto, Y., Tomono, K., Tashiro, T., Seki, J., Tomii, Y., Sonoke, S., & Kohno, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.471 · Cited by 32
Robbie, G., & Chiou, W. L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011923704731 · Cited by 29
Brajtburg, J., Elberg, S., Kobayashi, G. S., & Bolard, J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.300 · Cited by 28
Brime, B. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg266 · Cited by 28
Kuti, J. L., Kotapati, S., Williams, P., Capitano, B., Nightingale, C. H., & Nicolau, D. P. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422050-00004 · Cited by 26
PEG-phospholipid micelles for the delivery of amphotericin B.
Vakil, R., & Kwon, G. S. (2005) · PubMed · Cited by 25
Interaction of amphotericin B with polymeric colloids
Espuelas, S., Legrand, P., Chéron, M., BARRATT, G. M., Puisieux, F., Devissaguet, J. P., & Irache, J. M. (1998) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(98)00033-2 · Cited by 22
Brime, B., Molero, G., Frutos, P., & Frutos, G. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.04.008 · Cited by 22
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B
Sánchez‐Brunete, J. A., Dea‐Ayuela, M. A., Rama, S., Bolás-Fernández, F., Alunda, J. M., Torrado, S., & Torrado, J. J. (2005) · Journal of drug targeting · doi:10.1080/10611860500097107 · Cited by 22
Self-citationAdams, M., & Kwon, G. S. (2004) · PubMed · Cited by 22
Amphotericin B — Not So Terrible
Bishara, J., Weinberger, M., Lin, A. Y., & Pitlik, S. D. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10240 · Cited by 18
Amphotericin B lipid complex: Review of safety, pharmacokinetics and efficacy
Dix, S. P., & Wingard, J. R. (1996) · Drugs of today · doi:10.1358/dot.1996.32.5.379050 · Cited by 17
Shadkchan, Y., Zaslavsky, Z., & Segal, E. (2003) · Medical Mycology · doi:10.1080/714043894 · Cited by 15
Cited by
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Amphotericin B: side effects and toxicity
Laniado-Laborín, R., & Cabrales-Vargas, M. N. (2009) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2009.06.003 · Cited by 739
Tissue Penetration of Antifungal Agents
Felton, T., Troke, P. F., & Hope, W. W. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-13 · Cited by 426
Moen, M. D., Lyseng-Williamson, K. A., & Scott, L. J. (2009) · Drugs · doi:10.2165/00003495-200969030-00010 · Cited by 321
Metadata
- Authors
- Torrado, J. J., Espada, R., Ballesteros, M. P., & Torrado-Santiago, S.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 97
- Issue
- 7
- Pages
- 2405-2425
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W1966469295
- Cited by
- 299
- References
- 117
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.